Verapamil-d 7

Overview

Verapamil -d 7 is the deuterium labeled Verapamil ( HY-14275 ). Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4 . Verapamil has the potential for high blood pressure, heart arrhythmias and angina research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Calcium Channel | Products > Signaling Pathways > P-glycoprotein | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-14275S1
• CAS No.: 100578-79-8
• Molecular Formula: C27H31D7N2O4
• Molecular Weight: 461.64
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source